Press Releases

 Filter by Provider

WELLESLEY HILLS, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conference detailed below.

REYKJAVIK, Iceland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows:

Caldera Therapeutics, Inc. (“Caldera”), a privately held clinical-stage biotechnology company developing CLD-423, a bispecific antibody targeting IL-23p19 and TL1A for the treatment of inflammatory bowel disease (IBD) and other immune-mediated diseases, today announced the appointments of Michelle Doig as Chief Financial Officer and Lee Giguere, J.D., as Chief Legal Officer.

SANTA MONICA, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on December 28, 2026, to stockholders of record at the close of business on December 14, 2026.

Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence in care decisions

Former NYPD Deputy Commissioner Edward Delatorre Jr. brings 46 years of law enforcement leadership and proven experience turning lifesaving interventions into department-wide operational capabilities

BOSTON and SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced the closing of its previously announced separate underwritten public offerings of 9,761,905 shares of its common stock, which includes the exercise in full of the underwriters’ option to purchase up to 1,428,571 additional shares of its common stock, at a public offering price of $21.00 per share (the “Offering Price”) and, in lieu of common stock to investors that so choose, pre-funded warrants to purchase up to 1,190,476 shares of its common stock at an offering price of $20.999 per pre-funded warrant, which represents the per share Offering Price less the $0.001 per share exercise price for each pre-funded warrant (the “common stock offering”) and $172.5 million aggregate principal amount of 2.25% convertible senior notes due 2032 (the “notes”), which includes the exercise in full of the underwriters’ over-allotment option to purchase up to an additional $22.5 million aggregate principal amount of notes (the “notes offering” and together with the common stock offering, the “underwritten offerings”). Concurrently with the underwritten offerings, Rapport entered into a securities purchase agreement with a certain investor (the “Investor”), in a separately negotiated transaction (the “concurrent private placement” and together with the underwritten offerings, the “offerings”) pursuant to which Rapport sold to the Investor 1,428,571 shares of Rapport’s common stock, at the Offering Price. The sale of shares to the Investor in the concurrent private placement were not registered as part of the common stock offering.

– Afimetoran, an investigational oral, once-daily, equipotent TLR7/8 inhibitor, targets a central driver of lupus biology with the potential to address both cutaneous and systemic disease –

BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, today announced positive topline data in its Phase 2a INFORM-MS trial with intranasal foralumab (a human, anti-CD3 monoclonal antibody) in patients with non-active secondary progressive multiple sclerosis (na-SPMS).

MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that the Company will host a conference call on Tuesday, November 10, 2026, at 8:00 a.m. ET to discuss its business strategy and financial results for the third quarter ended September 30, 2026. The Company’s results will be reported in a press release prior to the call.

RONKONKOMA, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or the “Company”), a leading provider of residential and commercial solar energy systems, battery storage solutions and comprehensive energy services, today announced that it has confidentially submitted a draft registration statement on Form S-4 (the “Registration Statement”) to the U.S. Securities and Exchange Commission (“SEC”) in connection with its previously announced proposed merger with Suniva, Inc. (“Suniva”).

Allowed claims cover Lowe syndrome and Dent disease 2; Can-Fite holds development, commercialization, and out-licensing rights for these indications under its agreement with Fondazione Telethon

Zhengzhou, China--(Newsfile Corp. - November 2, 2026) - Zhengzhou LIVI Machinery Manufacturing Co., Ltd. (LIVI Machinery or LIVI) held its 2026 Brand Relaunch Conference and Global Partners Value Discovery Journey in Zhengzhou on October 24, 2026, bringing together customers and partners from dozens of countries. The event unveiled a renewed brand identity and created a forum for discussing practical challenges in poultry farming, including equipment selection, operating costs and after-sales support.

Xcel Energy Inc. (NASDAQ: XEL) (“Xcel Energy”) today announced that it intends to offer, subject to market and other conditions, $2,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the “convertible notes”) in a private placement under the Securities Act of 1933, as amended (the “Securities Act”). Xcel Energy also intends to grant the initial purchasers of the convertible notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the convertible notes are first issued, up to an additional $300,000,000 aggregate principal amount of the convertible notes.

The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today that the City of Big Spring, Texas has entered into a 10-year intergovernmental service agreement with U.S. Immigration and Customs Enforcement (“ICE”) for the activation of a federal immigration processing center at the 2,329-bed Big Spring Complex in Texas (the “Big Spring Complex”), comprised of the 1,404-bed Flightline Facility and the 925-bed Cedar Hill Facility.

Kontoor Brands, Inc. (NYSE: KTB) today announced plans to release its third quarter 2026 financial results on Thursday, November 5, 2026, at approximately 6:50 a.m. ET.

DEER PARK, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced ET-900, a new development program evaluating mecasermin injection for the treatment of infantile and epileptic spasms. Mecasermin is a recombinant form of IGF-1 and the active ingredient in INCRELEX, which Eton markets in the United States. The Company has entered into a license agreement with Baylor College of Medicine covering patent rights related to the use of IGF-1 for the treatment of spasms.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data across its HIV treatment and prevention pipeline and portfolio will be presented at HIV Drug Therapy Glasgow 2026 (HIV Glasgow 2026), taking place Nov 8–11, 2026, in Glasgow, Scotland. Presentations will highlight Merck’s strategy to expand oral options in both HIV treatment and prevention, including data on once-daily IDVYNSO® (doravirine/islatravir), the investigational once-weekly oral treatment regimens islatravir/lenacapavir (ISL/LEN) and islatravir/ulonivirine (ISL/ULO), and the investigational once-monthly oral pre-exposure prophylaxis (PrEP) alimatravir (AMI, MK-8527).

Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”) on October 29, 2026. The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged.

As previously announced, RPM International Inc. (NYSE: RPM), a world leader in specialty coatings, sealants and building materials, will host an Investor Day on Monday, November 9, 2026, where the company will provide details on MAP 2030, its next operating improvement program, as well as updates on other key business initiatives.

NIQ (NYSE: NIQ), a leading consumer intelligence company, today released its 2026 Environmental, Social and Governance (ESG) Progress Report, detailing the company’s progress on key ESG priorities throughout 2025. The report covers NIQ’s efforts across environmental responsibility, its people and communities, data integrity, and responsible AI.

WATERLOO, Ontario and ATLANTA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that its Descartes MacroPoint™ Advanced Ocean Visibility solution is now integrated with SAP Business Network Freight Collaboration and SAP Business Network Global Track and Trace through a standardized connection to the Descartes Global Logistics Network™ (Descartes GLN™). The combined solution provides shippers with access to expanded multimodal visibility capabilities within their SAP transportation environments.

WATERLOO, Ontario and ATLANTA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its third-quarter fiscal 2027 financial results after market close on Wednesday, December 2, 2026.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter Phase 2 UNICORN trial evaluating short-course preoperative, or neoadjuvant, botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, alone or in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody, in patients with resectable, locally advanced colon cancer. The manuscript, titled “Preoperative botensilimab with or without balstilimab for patients with resectable, locally advanced pMMR or dMMR colon cancer: the UNICORN trial by GONO,” was published in Nature Medicine and is available at DOI 10.1038/s41591-026-04710-1.

Online curriculum expands with advanced clinical cases in prostate cancer and neuroendocrine tumors including multidisciplinary tumor board illustrations

OpZira™, Inc., an ophthalmic medical device company advancing technologies for the detection and monitoring of ocular disease, today announced its subsidiary, AdaptDx, Inc., has completed its Stage II audit at the company's Lighthouse medical device manufacturing facility. The audit represents an important step in the ISO certification process and supports OpZira's plans to pursue CE marking for AdaptDx Pro® in the European Union in 2027.

Sinda Ltd. (NYSE: SIND) (“Sinda” or the “Company”) today announced third quarter 2026 results and the filing of its Form 10-Q.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Black Book's 94-page report examines how hospital boards, CIOs and CFOs can turn operating changes into sustainable AI funding while protecting patients, staff and essential services.

TORONTO, ON / ACCESS Newswire / November 2, 2026 / Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX:JAG) is providing an update on the licensing of its Onças de Pitangui underground gold project in Minas Gerais, Brazil (the "Project"). On October 30, 2026, the state environmental authority (URA Alto São Francisco, FEAM) issued a decision denying the Project's combined Preliminary and Installation Licence (LP+LI) application.

New analysis of provincial marriage records identifies August 14, 21 and 28 and September 4 as potential peak wedding dates, amid a continuing decline in Saturday ceremonies.

Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Mayfair Gold Corp. (TSXV: MFG) (NYSE American: MINE) ("Mayfair" or the "Company") is pleased to announce that its 100%-owned Fenn-Gib Gold Project ("Fenn-Gib" or the "Project"), located in the Timmins region of Northern Ontario, has been selected as a designated project under the Government of Ontario's new "One Project, One Process" ("1P1P") framework. The designation is expected to streamline permitting and provide more predictable timelines. Mayfair expects the designation to accelerate progress toward a construction decision and, ultimately, production and free cash flow1.

GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with more than 20 years of successful operations across Latin America, today announced the effectiveness of the 25-year Production Participation Contract (“CPP”) for the Bare Block in Venezuela (the “Bare Block”), together with the completion of the related share issuance transaction with Grupo Gilinski.

Matador Resources Company (NYSE: MTDR) (“Matador”) today announced that wholly owned subsidiaries of San Mateo Midstream, LLC (“San Mateo” or the “Company”), Matador’s 51%-owned midstream joint venture with Five Point Infrastructure LLC (“Five Point”), have entered into two agreements with a large producer in the Northern Delaware Basin:

San Mateo Midstream, LLC (“San Mateo”), a joint venture between Matador Resources Company (NYSE: MTDR) (“Matador”) and Five Point Infrastructure LLC (“Five Point”), today announced that two of its wholly-owned subsidiaries have entered into two agreements with a large producer in the Northern Delaware Basin:

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, in partnership with the Depression and Bipolar Support Alliance (DBSA), today released a new report summarizing findings from a national survey of people living with TRD (n=261) and caregivers (n=73) on the self-reported realities of living with a condition that can profoundly affect daily life, revealing the burden of prolonged depressive episodes without meaningful relief.

IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on October 30, 2026.

Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, today announced financial results for the third quarter ended September 30, 2026.

Specialty insurance builder to lead GBLI, Katalyx and Belmont and put the Company’s proprietary technology and national distribution to work

NEW YORK and TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Canada Pension Plan Investment Board (“CPP Investments”), today announced the completion of their acquisition of LXP Industrial Trust (“LXP”) in an all-cash transaction.

William Mills Agency, the nation’s leading fintech public relations and marketing firm, today announced the release of its 2027 Financial Trade Show Guide. The annual guide lists trade shows and conferences across the financial, banking, mortgage, lending, payments, fintech and credit union sectors.

HONG KONG, CHINA: HONG KONG, CHINA – Media OutReach Newswire – 2 November 2026 – Last week, the China Telecom Smart APAC · AI Innovation Summit was held in Bangkok, Thailand

Running a small business means dealing with customers all day. Some want to know the price of a product, others ask about delivery, and a few are ready to place an order. For many businesses, most of these conversations now happen on WhatsApp. It's quick, familiar and convenient. Customers don't…

Avolon, a leading global aviation finance company, today announced an agreement to establish Constellation Aviation (“Constellation”), a new aircraft leasing infrastructure investment platform formed through a joint venture with I Squared Capital, a leading infrastructure investor, and a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”).

Mr. Walle Brings Capital Market Expertise and Extensive Audit Partner Experience to Ur-Energy

The Global Data Ecosystem Conference 2026

Bank feeds have made it considerably easier for accountants to keep track of transactions within a self-managed super fund. Payments and deposits can be imported automatically, saving time that would otherwise be spent entering figures manually. However, while a bank feed can tell you how much money has moved and when, it doesn’t always tell you why.

STUDIO CITY, Calif., Nov. 2, 2026 (SEND2PRESS NEWSWIRE) -- Kord Fire Protection is highlighting the importance of routine fire pump churn testing, a required maintenance activity that helps commercial property owners and facility managers evaluate fire pump operation between annual flow tests. A churn test, also called a no-flow test, involves operating a fire pump without delivering water through the system's test outlets.